Open AccessCRISPR-Cas System: A Promising Diagnostic Tool for Covid-19
Author(s) -
Saeedeh Ebrahimi,
Hashem Khanbabaei,
Samaneh Abbasi,
Mona Fani,
Saber Soltani,
Milad Zandi,
Zahra Najafimemar
Publication year - 2022
Publication title -
avicenna journal of medical biotechnology.
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.399
H-Index - 22
eISSN - 2008-4625
pISSN - 2008-2835
DOI - 10.18502/ajmb.v14i1.8165
Subject(s) - crispr , pandemic , covid-19 , diagnostic test , intensive care medicine , disease , virology , coronavirus , medicine , biology , infectious disease (medical specialty) , pathology , pediatrics , genetics , outbreak , gene
More than a year has passed since the beginning of the 2019 novel coronavirus diseases (COVID-19) pandemic which has created massive problems globally affecting all aspects of people's life. Due to the emergence of new strains of the SARS-CoV-2, pandemic risk still remains, despite the start of vaccination. Therefore, rapid diagnostic tests are essential to control infection, improve clinical care and stop the spread of the disease. Recently CRISPR-based diagnostic tools have facilitated rapid diagnostic. Here, we review the diagnostic applications of CRISPR-Cas system in COVID-19.